A quick peek into the report
Table of Contents
1.1 The Basic NGS Workflow
1.2 Historical Trends
1.3 Comparative Analysis of Sanger Sequencing and Next-Generation Sequencing
1.4 Global NGS Market Scenario
1.5 Assumptions and Limitations
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Growing Demand for Non-Invasive Diagnosis
2.2.2 Technological Advancements in the Field of Computational Biology
2.2.3 Growing Prominence of Precision Medicine
2.3 Market Restraints
2.3.1 Uncertain Reimbursement and Regulatory Policies
2.3.2 Expensive Sequencing Procedures and Their Applications in Medical Treatments
2.3.3 High Capital Requirement Hampering the Expansion of Global Reach
2.4 Market Opportunities
2.4.1 Development of Portable Technologies
2.4.2 Hybridization of Technologies
2.4.3 Technological Developments in the Field of Bioinformatics and Automation Software
3.1 Key Strategies and Developments
3.1.1 Product Launch and Enhancements
3.1.2 Collaborations, Partnership, Joint Ventures, and Agreements
3.1.3 Mergers and Acquisition
3.1.4 Business Expansion and Others
3.2 Market Share Analysis (2016 and 2017)
3.2.1 Market Share Analysis, by Company, by Instruments
3.2.2 Market Share Analysis, by Company, by Kits and Consumables
3.3 Growth Share Analysis
3.3.1 Growth Share Analysis (by Products)
3.3.2 Growth Share Analysis (by Sequencing Instruments Provider)
3.4 Value Chain Analysis
3.4.1 Value Chain Analysis of Medical Device Industry
3.4.2 Value Chain Analysis: Illumina, Inc.
3.5 $100 per Genome: Era of Predictive and Personalized Medicine
3.6 Industry Attractiveness
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyer
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitute Products
3.6.5 Intensity of Competitive Rivalry
4.1 Emerging Companies and Leading Investors of NGS Market
4.2 Legal Requirements and Regulations
4.3 Role of Service Provider in the Next-Generation Sequencing Market
5.1 Instruments
5.2 Kits and Consumables
5.2.1 Supply Chain of NGS Kits and Consumables
5.2.1.1 Key Challenges for MedTech Supply Chain
5.2.1.2 Supply Chain Model: Next-Generation Sequencing Market
5.2.1.3 Thermo Fisher Scientific
5.2.1.4 QIAGEN N.V.
5.2.1.5 PerkinElmer, Inc.
5.2.1.6 Pacific Biosciences of California, Inc.
5.2.1.7 Oxford Nanopore Technologies Limited.
5.2.1.8 NuGEN Technologies, Inc.
5.2.1.9 New England Biolabs, Inc.
5.2.1.10 Illumina, Inc.
5.2.1.11 F. Hoffmann-La Roche AG
5.2.1.12 Danaher Corporation
5.2.1.13 ASURAGEN, INC
5.2.1.14 Agilent Technologies, Inc.
5.2.1.15 Adaptive Biotechnologies.
5.2.1.16 10x Genomics
5.3 Software
6.1 Reversible Terminator Sequencing
6.2 Ion Torrent Semiconductor Sequencing
6.3 Single Molecule Real Time Sequencing (SMRT)
6.4 Nanopore Sequencing Technology
6.5 Others
7.1 Pharmaceuticals
7.2 Diagnostics
7.3 Agricultural and Animal Research
7.4 Forensics
7.5 Others
8.1 North America
8.1.1 North America: Market Dynamics
8.1.2 North America NGS Market (by Product), 2018-2024
8.1.3 North America NGS Market: Market Share, by Company
8.1.4 North America NGS Market, (by Country)
8.1.4.1 The U.S.
8.1.4.2 Canada
8.2 Europe
8.2.1 Europe: Market Dynamics
8.2.2 Europe NGS Market (by Product), 2018-2024
8.2.3 Europe: Market Share, by Company
8.2.4 Europe NGS Market, by Country
8.2.4.1 Germany
8.2.4.2 The U.K.
8.2.4.3 France
8.2.4.4 Italy
8.2.4.5 Spain
8.2.4.6 The Netherlands
8.2.4.7 Sweden
8.2.4.8 Denmark
8.2.4.9 Rest-of-Europe
8.3 Asia-Pacific
8.3.1 Asia-Pacific: Market Dynamics
8.3.2 Asia-Pacific NGS Market (by Product), 2018-2024
8.3.3 Asia-Pacific, by Country
8.3.3.1 China
8.3.3.2 Japan
8.3.3.3 Australia
8.3.3.4 India
8.3.3.5 South Korea
8.3.3.6 Singapore
8.3.3.7 Rest-of-the-Asia-Pacific
8.4 Latin America
8.4.1 Latin America: Market Dynamics
8.4.2 Latin America NGS Market (by Product), 2018-2024
8.4.3 Latin America: Market Share, by Company
8.4.4 Latin America, by Country
8.4.4.1 Brazil
8.4.4.2 Mexico
8.4.4.3 Rest-of-Latin America
8.5 Rest-of-the-World
8.5.1 Rest-of-the-World NGS Market (by Product), 2018-2024
9.1 Overview
9.2 10x Genomics
9.2.1 Company Overview
9.2.2 Role of 10x Genomics in the Global NGS Market
9.2.3 SWOT Analysis
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Role of Agilent Technologies, Inc. in the Global NGS Market
9.3.3 Financials
9.3.3.1 Key Insights about Financial Health of the Company
9.3.4 SWOT Analysis
9.4 Bio-Rad Laboratories, Inc
9.4.1 Company Overview
9.4.2 Role of Bio-Rad Laboratories, Inc. in the Global NGS Market
9.4.3 Financials
9.4.3.1 Key Insights about Financial Health of the Company
9.4.4 SWOT Analysis
9.5 BGI
9.5.1 Company Overview
9.5.2 Role of BGI in the Global NGS Market
9.5.3 SWOT Analysis
9.6 bioMérieux SA
9.6.1 Company Overview
9.6.2 Role of bioMérieux SA in the Global NGS Market
9.6.3 Financials
9.6.3.1 Key Insights about Financial Health of the Company
9.6.4 SWOT Analysis
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Role of Danaher Corporation in the Global NGS Market
9.7.3 Financials
9.7.3.1 Key Insights about Financial Health of the Company
9.7.4 SWOT Analysis
9.8 F. Hoffmann-La Roche AG
9.8.1 Company Overview
9.8.2 Role of F. Hoffmann-La Roche AG in the Global NGS Market
9.8.3 Financials
9.8.3.1 Key Insights about Financial Health of the Company
9.8.4 SWOT Analysis
9.9 Illumina, Inc.
9.9.1 Company Overview
9.9.2 Role of Illumina, Inc. in the Global NGS Market
9.9.3 Financials
9.9.3.1 Key Insights about Financial Health of the Company
9.9.4 SWOT Analysis
9.10 New England Biolabs, Inc
9.10.1 Company Overview
9.10.2 Role of New England Biolabs, Inc. in the Global NGS Market
9.10.3 SWOT Analysis
9.11 NuGEN Technologies, Inc.
9.11.1 Company Overview
9.11.2 Role of NuGEN Technologies, Inc. in the NGS Market
9.11.3 SWOT Analysis
9.12 Oxford Nanopore Technologies Limited
9.12.1 Company Overview
9.12.2 Role of Oxford Nanopore Technologies Limited in the Global NGS Market
9.12.3 SWOT Analysis
9.13 Pacific Biosciences of California, Inc.
9.13.1 Company Overview
9.13.2 Role of Pacific Biosciences of California, Inc. in the Global NGS Market
9.13.3 Financials
9.13.3.1 Key Insights on the Financial Health of the Company
9.13.4 SWOT Analysis
9.14 QIAGEN N.V.
9.14.1 Company Overview
9.14.2 Role of QIAGEN N.V. in the Global NGS Market
9.14.3 Financials
9.14.3.1 Key Insights about Financial Health of the Company
9.14.4 SWOT Analysis
9.15 PerkinElmer, Inc.
9.15.1 Company Overview
9.15.2 Role of PerkinElmer, Inc. in the Global NGS Market
9.15.3 Financials
9.15.3.1 Key Insights on the Financial Health of the Company
9.15.4 SWOT Analysis
9.16 Thermo Fisher Scientific
9.16.1 Company Overview
9.16.2 Role of Thermo Fisher Scientific in the Global NGS Market
9.16.3 Financials
9.16.3.1 Key Insights about Financial Health of the Company
9.16.4 SWOT Analysis
10.1 Report Scope
10.1.1 Global Next-Generation Sequencing Market: Research Methodology
10.1.2 Primary Data Sources
10.1.3 Secondary Data Sources
10.1.4 Data Triangulation
10.1.5 Assumptions and Limitations
10.1.6 Data and Prediction Modelling
11.1 Annexure I : Key Developments and Strategies (January 2014 to February 2019)
11.2 Annexure II : Product Mapping
Table 1.1: Sanger Sequencing vs. Next-Generation Sequencing
Table 2.1: Impact Analysis
Table 4.1: Funding Scenario
Table 4.2: Regulatory Bodies
Table 4.3: Country-Wise Service Providers
Table 5.1: Global NGS Instruments Market (by Type), 2018-2024, $Million
Table 5.2: Global NGS Kits and Consumables Market (by Type), 2018-2024, $Million
Table 5.3: Few Suppliers of Thermo Fisher Scientific
Table 5.4: Few Suppliers of QIAGEN N.V.
Table 5.5: Few Suppliers of PerkinElmer, Inc.
Table 5.6: Few Suppliers of Pacific Biosciences of California, Inc.
Table 5.7: Few Suppliers of Oxford Nanopore Technologies Limited.
Table 5.8: Few Suppliers of NuGEN Technologies, Inc.
Table 5.9: Few Suppliers of New England Biolabs.
Table 5.10: Key Offerings of Illumina, Inc.
Table 5.11: Few Suppliers of Illumina, Inc.
Table 5.12: Few Suppliers of F. Hoffmann-La Roche AG
Table 5.13: Few Suppliers of Danaher Corporation
Table 5.14: Few Suppliers of ASURAGEN, INC.
Table 5.15: Few Suppliers of Agilent Technologies, Inc.
Table 5.16: Few Suppliers of Adaptive Biotechnologies.
Table 5.17: Few Suppliers of 10x Genomics
Table 6.1: Reversible Terminator Sequencing Country Wise Service Providers
Table 6.2: Ion Torrent Semiconductor Sequencing Country Wise Service Providers
Table 6.3: Single Molecule Real-Time Sequencing Country Wise Service Providers
Table 8.1: North America Next-Generation Sequencing Market (by Product), 2018-2024, $Million
Table 8.2: Europe Next-Generation Sequencing Market Revenue (by Product), 2018-2024, $Million
Table 8.3: Asia-Pacific Next-Generation Sequencing Market Revenue (by Product), 2018-2024, $Million
Table 8.4: Latin America Next-Generation Sequencing Market Revenue (by Product), 2018-2024, $Million
Table 8.5: Rest-of-the-World: Next-Generation Sequencing Market Revenue (by Product), 2018-2024, $Million
Figure 1: Drivers and Restraints of Next-Generation Sequencing Market
Figure 2: Key Strategies Incorporated by Stakeholders of NGS Market, to Sustain the Compatation (from January 2014 to February 2019)
Figure 3: Leading Service Providers in the Next-Generation Sequencing Market
Figure 4: Global Next-Generation Sequencing Market, 2018-2024
Figure 5: Global Next-Generation Sequencing Market Share (by Product), 2018 and 2024
Figure 6: Global Next-Generation Sequencing Market Share (by Technology), 2018 and 2024
Figure 7: Global Next-Generation Sequencing Market Share (by Application), 2018 and 2024
Figure 8: Global Next-Generation Sequencing Market Share (by Region), 2018 and 2024
Figure 1.1: Different steps in Next-Generation Sequencing Technology
Figure 1.2: Evolution of Next-Generation Sequencers with Progress in Molecular Technologies
Figure 1.3: Global Next-Generation Sequencing Market, 2018-2024
Figure 2.1: Market Dynamics of Global NGS Market
Figure 3.1: Competitive Landscape, January 2014-February 2019
Figure 3.2: Share of Key Developments and Strategies, January 2014-February 2019
Figure 3.3: Product Launch and Enhancements Share (by Companies), January 2014-February 2019
Figure 3.4: Collaborations, Partnership, Joint Ventures, and Agreements Share (by Companies), January 2014-February 2019
Figure 3.5: Mergers and Acquisitions Share (by Companies), January 2014-February 2019
Figure 3.6: Business Expansion and Others Share (by Companies), January 2014-February 2019
Figure 3.7: Market Share Analysis (by Companies) for the Global Next-Generation Sequencing Market, 2016 and 2017
Figure 3.8: Market Share Analysis (by Companies) for the Global Next-Generation Sequencing Instruments Market, 2016 and 2017
Figure 3.9: Market Share Analysis (by Companies) for the Global Next-Generation Sequencing Kits and Consumables Market, 2016 and 2017
Figure 3.10: Growth Share Matrix for Global Next-Generation Sequencing Market (by Products), 2017
Figure 3.11: Growth Share Matrix for Global Next-Generation Sequencing Market (by Sequencing Instruments Provider), 2017
Figure 3.12: Key Entities of Value Chain
Figure 3.13: Value Chain of Medical Device Industry
Figure 3.14: Value Chain Analysis: Illumina, Inc.
Figure 3.15: Cost Per Genome Sequencing ($) vs. Maximum Output of Sequencer Per Run
Figure 3.16: Maximum Output per Run Required for $100 Genome Sequencing
Figure 4.1: Level of NGS Service Providers Presence
Figure 5.1: Global NGS Market (by Product Type)
Figure 5.2: Global NGS Market (by Product Type), 2018 and 2024
Figure 5.3: Pivotal Types of Instruments Associated with NGS
Figure 5.4: Global NGS Instruments Market, 2018-2024
Figure 5.5: Pivotal Types of Kits & Consumables Associated with NGS
Figure 5.6: Global NGS Kits & Consumables Market, 2018-2024
Figure 5.7: Key Entities of Supply Chain
Figure 5.8: Comparison of MedTech Industry and Total Consumer Industry Supply Chain
Figure 5.9: Supply Chain Model
Figure 5.10: Different Types of Computational Platforms
Figure 5.11: Global NGS Software Market, 2018-2024
Figure 6.1: Different Types of Sequencing
Figure 6.2: Global NGS Market (by Technology), 2018 and 2024
Figure 6.3: Global NGS Market for Reversible Terminator Sequencing, 2018-2024
Figure 6.4: Global NGS Market for Ion Torrent Semiconductor Sequencing, 2018-2024
Figure 6.5: Global NGS Market for Single Molecule Real-Time Sequencing, 2018-2024
Figure 6.6: Global NGS Market for Nanopore Sequencing Technology, 2018-2024
Figure 6.7: Global NGS Market for Other Technologies, 2018-2024
Figure 7.1: Leading Fields Which are Witnessing Colossal Incorporation of NGS
Figure 7.2: Global NGS Market (by Application), 2018-2024
Figure 7.3: Application of NGS in the field of Pharmaceuticals
Figure 7.4: Global NGS Market for Pharmaceuticals Applications, 2018-2024
Figure 7.5: Applications of NGS in the field of Diagnostics
Figure 7.6: Global NGS Market for Diagnostics Applications, 2018-2024
Figure 7.7: Global NGS Market for Agricultural and Animal Research Applications, 2018-2024
Figure 7.7: Global NGS Market for Forensics Applications, 2018-2024
Figure 7.8: Global NGS Market for Other Applications, 2018-2024
Figure 8.1: Global Next-Generation Sequencing Market (by Region), 2018 and 2024
Figure 8.2: North America: Next-Generation Sequencing Market, (2018-2024)
Figure 8.3: North America: Market Dynamics
Figure 8.4: Market Share Analysis: North America Sequencing Market, 2016 and 2017
Figure 8.5: North America: Next-Generation Sequencing Market (by Country), 2018 and 2024
Figure 8.6: The U.S.: Next-Generation Sequencing Market, 2018-2024
Figure 8.7: Canada.: Next-Generation Sequencing Market, 2018-2024
Figure 8.8: Europe: Next-Generation Sequencing Market, (2018-2024)
Figure 8.9: Europe: Market Dynamics
Figure 8.10: Market Share Analysis: Europe Sequencing Market, 2016 and 2017
Figure 8.11: Europe: Next-Generation Sequencing Market (by Country), 2018 and 2024
Figure 8.12: Germany: Next-Generation Sequencing Market, 2018-2024
Figure 8.13: The U.K.: Next-Generation Sequencing Market, 2018-2024
Figure 8.14: France: Next-Generation Sequencing Market, 2018-2024
Figure 8.15: Italy: Next-Generation Sequencing Market, 2018-2024
Figure 8.16: Spain: Next-Generation Sequencing Market, 2018-2024
Figure 8.17: The Netherlands: Next-Generation Sequencing Market, 2018-2024
Figure 8.18: Sweden: Next-Generation Sequencing Market, 2018-2024
Figure 8.19: Denmark: Next-Generation Sequencing Market, 2018-2024
Figure 8.20: Rest-of-Europe: Next-Generation Sequencing Market, 2018-2024
Figure 8.21: Asia-Pacific: Next-Generation Sequencing Market, (2018-2024)
Figure 8.22: Asia-Pacific: Market Dynamics
Figure 8.23: Market Share Analysis: Asia-Pacific Sequencing Market, 2016 and 2017
Figure 8.24: Asia-Pacific: Next-Generation Sequencing Market (by Country), 2018 and 2024
Figure 8.25: China: Next-Generation Sequencing Market, 2018-2024
Figure 8.26: Japan: Next-Generation Sequencing Market, 2018-2024
Figure 8.27: Australia: Next-Generation Sequencing Market, 2018-2024
Figure 8.28: India: Next-Generation Sequencing Market, 2018-2024
Figure 8.29: South Korea: Next-Generation Sequencing Market, 2018-2024
Figure 8.30: Singapore: Next-Generation Sequencing Market, 2018-2024
Figure 8.31: Rest-of-the-Asia-Pacific: Next-Generation Sequencing Market, 2018-2024
Figure 8.32: Latin America: Next-Generation Sequencing Market, (2018-2024)
Figure 8.33: Latin America: Market Dynamics
Figure 8.34: Market Share Analysis: Latin America Sequencing Market, 2016 and 2017
Figure 8.35: Latin America: Next-Generation Sequencing Market (by Country), 2018 and 2024
Figure 8.36: Brazil: Next-Generation Sequencing Market, 2018-2024
Figure 8.37: Mexico: Next-Generation Sequencing Market, 2018-2024
Figure 8.38: Rest-of-Latin America: Next-Generation Sequencing Market, 2018-2024
Figure 8.39: Rest-of-the-World: Next-Generation Sequencing Market, 2018-2024
Figure 9.1: Shares of Key Company Profiles
Figure 9.2: 10x Genomics Product Offerings for Global Next-Generation Sequencing Market
Figure 9.3: 10X Genomics: SWOT Analysis
Figure 9.4: Agilent Technologies, Inc. Product Offerings for Global Next-Generation Sequencing Market
Figure 9.5: Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 9.6: Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
Figure 9.7: Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 9.8: Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 9.9: Agilent Technologies, Inc.: SWOT Analysis
Figure 9.10: Bio-Rad Laboratories, Inc. Product Offerings for Global Next-Generation Sequencing Market
Figure 9.11: Bio-Rad Laboratories, Inc.: Overall Financials, 2015-2017
Figure 9.12: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2015-2017
Figure 9.13: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017
Figure 9.14: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2015-2017
Figure 9.15: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 9.16: BGI Product Offerings for Global Next-Generation Sequencing Market
Figure 9.17: BGI : SWOT Analysis
Figure 9.18: bioMérieux SA Product Offerings for Global Next-Generation Sequencing Market
Figure 9.19: bioMérieux S.A.: Overall Financials, 2015-2017
Figure 9.20: bioMérieux S.A.: Revenue (by Segment), 2015-2017
Figure 9.21: bioMérieux S.A.: Revenue (by Region), 2015-2017
Figure 9.22: bioMérieux S.A.: R&D Expenditure, 2015-2017
Figure 9.23: bioMérieux SA.: SWOT Analysis
Figure 9.24: Danaher Corporation Product Offerings for Global Next-Generation Sequencing Market
Figure 9.25: Danaher Corporation: Overall Financials, 2015-2017
Figure 9.26: Danaher Corporation: Revenue (by Segment), 2015-2017
Figure 9.27: Danaher Corporation: Revenue (by Region), 2015-2017
Figure 9.28: Danaher Corporation: R&D Expenditure, 2015-2017
Figure 9.29: Danaher Corporation: SWOT Analysis
Figure 9.30: F. Hoffmann-La Roche AG Product Offerings for Global Next-Generation Sequencing Market
Figure 9.31: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
Figure 9.32: F. Hoffmann-La Roche AG: Revenue (by Segment), 2016-2018
Figure 9.33: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
Figure 9.34: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
Figure 9.35: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 9.36: Illumina, Inc. Product Offerings for Global Next-Generation Sequencing Market
Figure 9.37: Illumina, Inc.: Overall Financials, 2016-2018
Figure 9.38: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 9.39: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 9.40: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 9.41: Illumina, Inc.: SWOT Analysis
Figure 9.42: New England Biolabs, Inc Product Offerings for Global Next-Generation Sequencing Market
Figure 9.43: New England Biolabs, Inc.: SWOT Analysis
Figure 9.44: NuGEN Technologies, Inc Product Offerings for Global Next-Generation Sequencing Market
Figure 9.45: NuGEN Technologies, Inc.: SWOT Analysis
Figure 9.46: Oxford Nanopore Technologies Limited Product Offerings for Global Next-Generation Sequencing Market
Figure 9.47: Oxford Nanopore Technologies Limited : SWOT Analysis
Figure 9.48: Pacific Biosciences of California, Inc. Product Offerings for Global Next-Generation Sequencing Market
Figure 9.49: Pacific Biosciences of California, Inc.: Overall Financials, 2015-2017
Figure 9.50: Pacific Biosciences of California, Inc.: Net Revenue by Region, 2015-2017
Figure 9.51: Pacific Biosciences of California, Inc.:R&D Expenditure 2015-2017
Figure 9.52: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 9.53: QIAGEN N.V.: Overall Product Portfolio
Figure 9.54: QIAGEN N.V.: Overall Financials, 2015-2017
Figure 9.55: QIAGEN N.V.: Revenue (by Segment), 2015-2017
Figure 9.56: QIAGEN N.V.: Revenue (by Region), 2015-2017
Figure 9.57: QIAGEN N.V.: R&D Expenditure, 2015-2017
Figure 9.58: QIAGEN N.V.: SWOT Analysis
Figure 9.59: PerkinElmer, Inc. Product Offerings for Global Next-Generation Sequencing Market
Figure 9.60: PerkinElmer, Inc.: Overall Financials, 2015-2017
Figure 9.61: PerkinElmer, Inc.: Net Revenue (by Segment), 2015-2017
Figure 9.62: PerkinElmer, Inc.: Net Revenue (By Region), 2015-2017
Figure 9.63: PerkinElmer, Inc.: Net Revenue (By Region), 2016-2018
Figure 9.64: PerkinElmer, Inc.: SWOT Analysis
Figure 9.65: Thermo Fisher Scientific: Overall Product Portfolio (NGS Market)
Figure 9.66: Thermo Fisher Scientific: Overall Financials, 2015-2017
Figure 9.67: Thermo Fisher Scientific: Revenue (by Segment), 2015-2017
Figure 9.68: Thermo Fisher Scientific: Revenue (by Region), 2015-2017
Figure 9.69: Thermo Fisher Scientific: R&D Expenditure, 2015-2017
Figure 9.70: Thermo Fisher Scientific: SWOT Analysis
Figure 10.1: Next-Generation Sequencing: Market Segmentation
Figure 10.2: Next-Generation Sequencing Market Segmentation
Figure 10.3: Primary Research
Figure 10.4: Secondary Research
Figure 10.5: Data Triangulation
Figure 10.6: Top-down Approach (Segment-wise Analysis)
Figure 10.7: Bottom-up Approach (Segment-wise Analysis)
Figure 10.8: Assumptions and Limitations
Figure 10.9: Considered Factors for Data Prediction and Modelling
Market Overview
Global Next-Generation Sequencing Market |
|||
Base Year |
2018 |
Market Size in 2020 |
$4.93 billion |
Forecast Period |
2019 -2024 |
Value Projection and Estimation by 2024 |
$9.91 billion |
CAGR During Forecast Period |
13.22% |
Number of Tables |
|
Number of Pages |
172 |
Number of Figures |
|
Market Segmentation |
· Application: Pharmaceuticals, Diagnostics, Agricultural and Animal Research, Forensics, Others Technology: Reversible Terminator Sequencing, Ion Torrent Semiconductor Sequencing, Single Molecule Real Time Sequencing (SMRT), Nanopore Sequencing Technology, Others. |
||
Regional Segmentation |
• North America - U.S., Canada. • Europe – Germany, U.K., France, Italy, Spain, Netherlands, Rest of Europe • Asia-Pacific – Japan, China, India, South Korea, Australia, Rest-of-Asia-Pacific • Rest-of-the-World |
||
Market Growth Drivers |
• Growing Demand for Non-Invasive Diagnosis • Technological Advancements in the Field of Computational Biology • Growing Prominence of Precision Medicine |
||
Market Challenges |
• Lack of Standardized Regulatory Framework Specific to Biometric Data Protection • Cost Concerns for End Users to Launch Biometric Solutions as Direct Paid Service |
||
Market Opportunities |
• Development of Portable Technologies • Hybridization of Technologies • Technological Developments in the Field of Bioinformatics and Automation Software |
||
Key Companies Profiled |
Agilent Technologies, Inc.; BGI; Danaher Corporation; F. Hoffmann-La Roche AG; New England Biolabs, Inc; Oxford Nanopore Technologies Limited; Thermo Fisher Scientific; QIAGEN N.V. |
Report Description
The global Next Generation Sequencing (NGS) industry is a multibillion-dollar marketplace that consists of many different companies, all involved in making instruments, kits, and consumables and developing software to bolster the NGS workflow. Next-generation sequencing allows scientists to sequence an entire genome, exome, or transcriptome within reach of all labs around the globe. With NGS technology, it has become possible to conduct experiments that were previously impossible to conduct. There were limitations with traditional sequencing platforms. Using them, scientists could sequence read lengths that were shorter than 1 kb, thus requiring a scale up to millions of fragments sequenced in parallel.
Over the years, advancements in sequencing chemistry, molecular biology, and technical engineering have allowed for a significant increase in efficiency as well as decreased cost. Improvements such as these have paved the way for the development of massively parallel, high-throughput sequencing technology, known as Next generation Sequencing (NGS).
The purpose of this next-generation sequencing report is to gain a holistic view of the next generation sequencing market growth in terms of various influencing factors, such as trends, technological advancements, the role of service providers, and funding scenarios in the market. The scope of this report constitutes an in-depth study of the next-generation sequencing industry across different regions worldwide.
The market has been split into ‘technology’, ‘product’, ‘application’, and ‘geographical regions’. The report presents the reader with an opportunity to get an in-depth insight into the market and helps form well-informed strategic decisions. The research uncovers some of the crucial parameters that must be considered before entering the market or parts of it.
This research report aims to answer various aspects of the global NGS market with the help of key factors driving the market, restraints, and challenges that can inhibit overall NGS market growth. It also provides insights into the current growth opportunities that are likely to shape the future trajectory of the market expansion.
The NGS report includes an exhaustive examination of the key players, developments, and the market as a whole. In addition, the report includes market dynamics (market drivers, opportunities, and challenges) and industry analysis.
The report evaluates the market share analysis of a comprehensive understanding of the global NGS market and comprehensively assesses the factors governing the same. Funding scenarios, Porter’s Five Force analysis, value chain analysis, opportunity matrix, detailed product mapping, growth share analysis, supply chain of NGS kits and consumables, and pricing analysis have been included in this report.
In the past few years, genome sequencing has been revolutionized by automated sanger sequencing. Sanger sequencing had limitations that led to the development of improved sequencing technologies capable of sequencing a large number of human genomes and are also capable of addressing the problems that were initially hindering the growth of the next-generation sequencing industry.
In addition, several research centers initiated the creation of new sequencing technologies, which allowed for the simultaneous sequencing of large numbers of samples. The three parallel technologies that were introduced in the early 21st century are Polonator, the Heliscope Single Molecule Sequencer Technology, and the Ion Torrent Semiconductor Sequencing. While several techniques have been developed over the past years to make sequencing more effective, it wasn't until recently that one could see a substantial leap forward in this area.
Two technologies that can drastically reduce the current cost of sequencing a human genome are Pacific Bio's single-molecule real-time (SMRT) DNA sequencing and nanopore DNA sequencing. The advent of the technologies mentioned above has unleashed some new methods that can make the $100 genome dream a reality in the near future. These high-throughput sequencing methods have introduced new fields in the industry, including analysis of RNA transcript, personal genomics, ChiP-Seq (Chromatin Immunoprecipitation sequencing), and ChiP-chip (Chromatin Immunoprecipitation coupled to DNA microarray), among others.
NGS requires infrastructure including storage, computer capacity, and human expertise to analyze and interpret data in the clinical setting. In addition, the lab technicians must have the expertise required to skillfully manage the data and extract clinically essential functions keeping quality standards high.
The purpose of this study is to gain a holistic view of the next-generation sequencing market size in terms of various influencing factors, such as recent trends, technological advancements, and regulatory aspects of the market. This study will present an overview of next-generation sequencing technologies used in the current industry, with predictions for future applications.
The global NGS market is segmented into four sections: product, technology, application, and geography. The global market value was estimated using these four different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation and to gain an in-depth view of the market.
The global next-generation sequencing market was $4.93 billion in 2018 and is estimated to grow over $9.91 billion by 2024. The global next-generation sequencing market share is expected to grow with a double-digit compound annual growth rate between the years 2019 and 2024.
With the growing demand for genome mapping programs and diagnostics tests based on sequencing, the sequencing market is expected to grow dramatically within the next few years. Clearly, this is an area where there will be further growth potential for investors who want to get in early on, something that only has room to improve over time. In terms of products, the kits and consumables sub-segment dominated the global next-generation sequencing market in 2018. However, the software sub-segment is expected to witness the highest CAGR in the forecast period from 2019 to 2024.
The global NGS market is dominated by reversible terminator sequencing currently. However, Nanopore sequencing technology market is estimated to witness the highest CAGR in the forecast period.
By application, presently, the pharmaceuticals field holds the largest share of the global next-generation sequencing market. It is expected to grow at 13.22% CAGR in the forecast period from 2019 to 2024. The demand for non-invasive diagnostic procedures is increasing. Therefore the diagnostic field is expected to witness an impressive CAGR in the forecast period from 2019 to 2024.
Geographical regions segment the global NGS market into North America, Europe, Latin America, Asia-Pacific, and Rest-of-the-World (RoW). North America is the leading contributor to the global next-generation sequencing market and contributed to 48% of the global market values in 2018. However, Asia-Pacific is expected to grow at a CAGR of 17.25% in the forecast period 2019-2024. Moreover, the Asia Pacific market contributed approximately 18.95% of the total global market value in 2018.
With the introduction of portable technologies, a paradigm shift in the dynamic market is expected in 2023. The leading players in the market are taking the necessary steps to tackle the shift in the dynamics and sustain the competition. U.S. players majorly dominate the global next-generation sequencing market. Companies belonging to the U.S., such as Illumina, Inc., and Thermo Fisher Scientific, contributed to more than 70% of the market value in 2018. The key players which have significant contributions to the NGS market are 10x Genomics, Agilent Technologies, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, GenapSys, Inc., Illumina, Inc., New England Biolabs, Inc., NuGEN Technologies Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN, and Thermo Fisher Scientific, among others.
The healthcare industry is becoming widely aware that genome sequencing-based technology and the use of service-providing companies will manifest into a lucrative business across the globe. The next-generation sequencing services market has grown with the growing popularity and acceptance of noninvasive prenatal testing, companion diagnostics, and liquid biopsy procedures using genome sequencing.
Additionally, there have been increasing investments in bioinformatics startups and service-providing companies. The growing demand for genome mapping programs along with the expanding availability of genomic data, is having a massive impact on the growth of the bioinformatics industry. Service-providing companies help expand the global reach of the key players of the market and play a significant role in increasing the adoption of sequencing technologies across the globe.
Among the many opportunities that are currently the subject of considerable work in the market right now are something called ‘hybrid technologies’ and the development of portable technologies. The best sequencer is the one with the ability to sequence long reeds, in short run time, and with great accuracy. The presently available sequencers on the market possess any one of the mentioned features, but not all three.
Despite the substantial amount of investment that companies have made into developing instruments that would possess these features mentioned above, it is not expected to become a reality soon. Therefore, it is believed that hybridization of available technologies, such as Single Molecule Real-Time sequencing technology and Reversible Semiconductor Sequencing Technology, will successfully provide solutions for this growing need.
Key Questions Answered in this Report
• What are the major market drivers, challenges, and opportunities in the global next generation sequencing market?
• How did the NGS market evolve, and what is its scope in the future?
• What was the market share of the leading segments and sub-segments of the global NGS market in 2018?
• How is each segment of the global NGS market expected to grow during the forecast period, and how much revenue is expected to be generated by each segment by the end of 2024?
• What are the influencing factors that may affect the global NGS market share of the key players?
• What is the influential stake held by the sequencing technology providers in the global NGS market?
• What is the growth potential of different sequencing technologies in the forecast period 2019-2024?
• What is expected to be the impact of commercialization of the portable sequencers on the global healthcare industry?
• What are the required features for an instrument to make $100 per genome sequencing a reality?
• What is the industry’s best value chain practice?
• What is the segmentation of the NGS Market by Product Type?
• What is the segmentation of the NGS Market by Technology?
• What is the segmentation of the NGS Market by Application?
• What is the segmentation of the NGS Market by Region?
• Which are the leading raw material providers to the players offering NGS kits and consumables?
• What is the market dominance by key players in each region?
• How is the next generation sequencing industry expected to evolve during the forecast period 2019- 2024?
• What are the key developmental strategies that the key players implement to stand out in this market?
• Which are the key service providers of the NGS industry?
• What is the funding scenario for the emerging companies that are investing a substantial amount into the development of promising technologies or products for bringing forth the evolution of the NGS market?
• How has the market been segmented based on sequencing technology? Which NGS technology is being adopted extensively for undertaking the sequencing procedure?
• What is the market share of the companies by different segments, namely products, technology, applications, and geography, along with the global share analysis of the market?
Global Next-Generation Sequencing Market
Focus on Products and Services, Applications, Technology, 18 Countries Data, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2024